Looking for an Opportunity to Create IMPACT? Explore Serving as a TLA Partner with a Purpose.
Category Archives: AZBio News
Ventana Planning New Distribution Center in Marana Arizona
Construction of a 60,000-square-foot logistics and distribution center for Ventana Medical Systems is scheduled to begin by year’s end in Marana.Continue reading
$9 Million Gift to Support the University of Arizona’s Veterinary Medical and Surgical Program
Thanks to a Kemper and Ethel Marley Foundation gift, the UA will be able to launch Arizona’s first public program to train Doctors of Veterinary Medicine.Continue reading
VENTANA System for Primary Diagnosis receives CE mark
New CE mark in the European Union extends application to routine pathology including primary diagnosis with human tissue specimens Continue reading
Are You Ready to Be The BUZZ of BIO?
BIO just announced the Buzz of BIO, recognizing the most innovative companies at annual BIO Investor Forum, an investor conference focused on early and established private companies as well as emerging public companies. This year’s event will take place October 7-8 in San Francisco.
Before the Recess: Washington Update for CSBA
Legislators wrapped up their summer work in July before leaving town for the August recess, but not without some last minute drama over the Highway Trust Fund (HTF) and the border supplemental bill. Ultimately, lawmakers passed a funding extension for the Highway Trust Fund (HTF), staving off a financial crisis. Congress also moved forward on several tax items and continued to hold oversight hearings on the Affordable Care Act (ACA) implementation.Continue reading
Transformational Gift to McKnight Brain Institute at the University of Arizona Launches Matching Campaign
The gift, and the matching contributions, will help the UA to play a prominent role in the emerging field of neuroscience.
Dad with Donor Heart Has Fingernails Painted Green by Baby Daughter, Thanks to the SynCardia Total Artificial Heart
A congenital heart defect brought Andrew Weaver close to death from end-stage biventricular heart failure. The SynCardia Heart kept him alive and helped build physical strength for his heart transplant.
Continue reading
Castle Biosciences Completes $11.8 M Financing
Castle Biosciences Inc., a cancer-focused molecular diagnostics company, today announced the completion of an $11.8 million financing. The round was led by new investor HealthQuest Capital, with participation by Castle Biosciences’ current investors including Mountain Group Capital and Affiliates, Longfellow Venture Partners and others. In conjunction with this financing, Garheng Kong, M.D., Ph.D., Managing Partner of HealthQuest Capital, will join Castle Biosciences’ Board of Directors.Continue reading